Press Releases

Strasbourg, France and Montreal, Canada, January 20, 2014 – Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces the opening of its North American...

Otsuka Pharmaceutical Co. Ltd. (Head office: Chiyoda-ku Tokyo; President Representative Director: Taro Iwamoto) signed a partnership agreement with the Olympic Council of Asia (OCA) for the 2014 Incheon Asian Games (Korea) and the 2019 Hanoi Asian Games (Vietnam) during...

Arcadia Biosciences Inc. and Genective S.A. a joint venture between Group LIMAGRAIN and Group KWS today announced that they have signed an agreement that will allow Genective to develop new corn hybrids incorporating Arcadia’s Water Use Efficiency (WUE) technology....

Adocia, a biotechnology company specializing in the development of ‘best-in-class’ medicines from already approved therapeutic molecules, in particular proteins and oncologic drugs, announces today that it has been granted two patents. The first patent is...

TxCell SA, a clinical stage biotechnology company developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today that Damian Marron, CEO, TxCell, will present at Biotech Showcase™ 2014, taking place January...

Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog(R),...

Domain Therapeutics, a France-based biopharmaceutical company that specializes in the research and development of new drug candidates that target G-protein coupled receptors (GPCRs), is pleased to announce the signing of a licensing and partnership agreement on GPCR biosensor technology...